Dr. Joseph Kozikowski will present on the use of nanoscale molecular imaging in translational medicine at Philips research global headquarters.
FRAMINGHAM, MA – December 1, 2006 – Clinivation, Inc. announced today that clinivation Founder and CEO Joseph Kozikowski, M.D. will present to research and executive leadership at Philips Research Eindhoven High Tech Campus.
As an authority on the development and commercialization of advanced medical technology, Dr. Kozikowski will share his perspectives in a presentation entitled “Optimizing Development: Translational Validation of Breast Cancer Targets” on December 15, 2006.
The presentation will address Dr. Kozikowski’s translational research in nanoscale molecular imaging and cancer as Chief Medical Officer and Study Medical Director of ART Advanced Research Technologies Inc. (Technoparc Saint-Laurent, CAN).
Quotes & Commentary:
“It is an honor to have been invited to present, and I thank the Philips executive leadership for their efforts in arranging this opportunity for learning,” said clinivation Founder and CEO Joseph Kozikowski, M.D.
About Philips Research Eindhoven:
Philips Research Eindhoven, located on the High Tech Campus (HTC) Eindhoven, is the global headquarters for Philips Research.
Royal Philips Electronics of the Netherlands is a diversified Health and Well-being company, focused on improving people’s lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of “sense and simplicity”. Headquartered in the Netherlands, Philips employs more than 118,000 employees in more than 60 countries worldwide.